Atricure Inc. buy UBS Group AG
Start price
30.10.24
/
50%
€29.29
Target price
30.10.25
€36.85
Performance (%)
3.79%
End price
31.10.25
€30.40
Summary
This prediction ended on 31.10.25 with a price of €30.40. The BUY prediction by UBS_Group_AG finished with a performance of 3.79%. UBS_Group_AG has a follow-up prediction for Atricure Inc. where he still thinks Atricure Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | 4.819% | 4.819% | -43.871% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $35.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten